|

US- sourced Opdivo® Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • mAbxience Research S.L.1

Indications

  • Advanced (Unresectable or Metastatic) Melanoma1
  • Cancer1

Other1 trial

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.